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Over the last three decades, the incidence of thyroid cancer has increased worldwide. The reasons for this increase remain
controversial. In Algeria, however, to date, information on thyroid cancer has been limited to a hospital-based case series. We
analyzed data from a population-based cohort study in Oran District, Algeria, to describe demographic and clinicopathological
characteristics of patients diagnosed with thyroid cancer between 1993 and 2013. Medical records and pathology reports of
thyroid cancer patients who had surgery were reviewed. Changes in demographic and clinicopathological features over the 21-
year period are described. During the study period, thyroid cancer was diagnosed in 1248 women (86.5%, mean age 43:7 ± 15:2
years) and 195 men (23.4%, mean age 48:1 ± 15:9 years). Most cases (83.1% for women and 69.8% for men) sought a diagnosis
following a self-neck check. The most common histologic types were papillary (58.3%), follicular (29.7%), anaplastic (4.1%), and
medullary (0.8%) carcinomas. The incidence of papillary carcinomas significantly increased (p < 0:001) while the incidence of
other histologic types significantly decreased over time. Tumor size overall significantly decreased (p < 0:001) while the
frequency of small (≤20mm) and larger (>20mm) carcinomas significantly increased (p < 0:05). The frequency of thyroid
cancers with capsular effractions and angioinvasions also decreased over time. Thyroid cancer incidence in Algeria has increased
substantially in line with international trends with changes in clinical practice being a possible contributing factor. However, the
increasing papillary-to-follicular cancer ratio may be due to changes in iodine nutrition status in Algeria. Further research,
including exploration of biological and molecular features of thyroid cancer, will enable a better understanding of risk factors
and etiopathogenetic mechanisms.
1. Background
Thyroid cancer (TC), although rare, is the most common
cancer affecting the endocrine system [1, 2]. In 2018,
567233 new TC cases were reported worldwide [3]. Incidence
rates are substantially higher among women (10.2 per
100000) than among men (3.1 per 100000) [3]. More than
95% of TCs are derived from follicular cells being classified
as differentiated, poorly differentiated (PDTC), and anaplas-
tic (ATC) TCs. The vast majority of differentiated TCs are
papillary (PTC) (70% to 90% of TC) or follicular (FTC)
(5%-10% of TC) carcinomas [2]. PTC and FTC have a good
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prognosis with 10-year survival rates of 80%-95% and 70%-
90%, respectively, whereas PDTC and ATC, which represent
the other 5%-10% of TCs, have much poorer prognosis [2, 4].
In Africa, PTC and FTC are the predominant histologic
types with a high proportion of FTCs (52.7% and 35.0%,
respectively) [5, 6]. This is not unexpected as in areas with
iodine deficiency and endemic goiter, such as Africa, FTC is
common [5]. Over the last three decades, TC incidence has
sharply increased in many parts of the world, particularly
the incidence of PTC and carcinomas ≤ 20mm, while the
incidence of other histologic subtypes has either declined or
remained stable [7–21]. The reasons for this are still debated.
Some authors have suggested that the increased TC incidence
is due to an increased use of thyroid ultrasound detecting
small tumors, while others suggest that changes in etiological
factors may play a role [21–23]. Among all risk factors
identified, exposure to ionizing radiation, especially in child-
hood, is the only clearly established and well-quantified risk
factor for TC, particularly PTC [24–26]. Other potential risk
factors include iodine deficiency and endemic goiter [27–30],
genetic susceptibility [31, 32], hormonal and reproductive
factors [33–35], obesity [36–38], and most recently exposure
to endocrine disruptors [39].
According to the International Agency for Research on
Cancer, in 2018, TC was the third most common cancer
among women and the eighth among men in Algeria [3].
TC incidence was 8.1 per 100000 in women and 1.9 per
100000 in men, with regional variations (6.2 per 100000 to
9.1 per 100000 for women and 1.4 per 100000 to 2.1 per
100000 for men). Over the last three decades, a steady increase
in TC incidence has been observed in the region of Setif in the
east of Algeria, known for its iodine deficiency and goiter
endemicity [40]. However, the clinical and histologic profile
of TC in Algeria has never been described, and most epidemi-
ologic studies have been based on a clinical series. We there-
fore used population-based data on TC, collected in the
district of Oran, Northwestern Algeria, to provide information
on TC incidence with a focus on its demographic, clinical, and
histological features.
2. Population and Methods
2.1. Study Design. We retrospectively reviewed the medical
records and pathology reports of TC patients who underwent
thyroid surgery between 1993 and 2013 in healthcare institu-
tions in the district of Oran and analyzed patterns and trends
of demographic and clinicopathological characteristics over
the 21-year period.
2.2. Case Definition. TC diagnosis is anatomopathological
based on microscopic examination of the thyroid specimen.
Morphological subtypes were defined according to definitions
of the World Health Organization (WHO): all TC cases
(topographic code C73.9) [41] were grouped into 6 major
morphological subtypes according to the International Classi-
fication of Diseases for Oncology, third edition (ICD-O-3)
[42]. PTC (ICD-O-3 codes: 8050, 8260, 8341-8344, 8350,
and 8450-8460), FTC (ICD-O-3 codes: 8190, 8290, and
8330-8335), papillary carcinoma of follicular variant (PTCFV)
(ICD-O-3 code: 8340), PDTC (ICD-O-3 code: 8300), ATC
(ICD-O-3 codes: 8012 and 8020-8035),MTC (ICD-O-3 codes:
8345, 8346, 8347, and 8510-8513), carcinomas with no other
specification (carcinoma NOS) (ICD-O-3 codes: 8000, 8010-
8015, 8230, and 8337), and other specified carcinomas (ICD-
O-3 codes: 8052, 8333, 8337, 8070, 8140, 9591, and 8800).
FVPTC cases were grouped with PTC, and PDTC with
ATC. The incidence date was determined using the definition
developed by the European Network of Cancer Registries [43].
2.3. Data Collection and Validation. As no dedicated clinico-
pathological database for TC exists in Oran, we collected data
using a multisource approach to enhance data completeness
and validity as recommended by the ENCR for population-
based cancer registries [44]. Information on clinically diag-
nosed TC patients was abstracted from medical records and
pathology reports of patients who underwent thyroid surgery
between 1 January 1993 to 31 December 2013, from 43
healthcare institutions across Oran, including public and
private clinics and pathology laboratories. To enhance data
completeness, we extended our search to all healthcare insti-
tutions involved in the diagnosis, management, treatment,
and follow-up of TC, nationwide. Our active search focused
on TC patients diagnosed with benign thyroid conditions,
including thyroid cold nodules and goiters and Grave’s
disease, and patients with clinically or cytologically
suspicious lesions who underwent either total or near-total
thyroidectomy followed by microscopic examination of the
thyroid specimen. We performed multiple crossovers
between the different data sources to validate the histopatho-
logical diagnosis and the place of residence of each patient.
Only patients with histologically confirmed TC and who
were permanent residents of the district of Oran at the time
of their TC diagnosis were included in the cohort. As pathol-
ogists do not report the place of residence on pathology
reports, TC cases that were identified through pathology
reports only were crossed with electoral lists in the munici-
palities to confirm residency. Information of interest
included age at TC diagnosis (or date of birth), sex, personal
history of benign diseases or malignancies, circumstances of
TC diagnosis, date and type of initial thyroid surgery (total
or near-total thyroidectomy), the presence of thyroid nodules
(TN) and their number, tumor size, capsular effractions,
angioinvasions, histologic type, and thyroid benign condition
associated with TC. All data were compiled in the same Excel
file, and duplicates excluded. For all TC patients included in
the study, a pathologist conducted a central review of pathol-
ogy reports in order to reascertain histological diagnosis.
2.4. Statistical Analysis
2.4.1. Definition of Variables. Variables considered in the
analysis included age at diagnosis (years), sex, circumstances
of TC diagnosis, personal history of thyroid diseases, inci-
dence date, period of TC diagnosis (1993-1997, 1998-2002,
2003-2007, and 2008-2013), major histologic subtypes (6
groups: PTC, FTC, ATC, MTC, other carcinomas specified,
and carcinoma NOS), the presence of thyroid nodules and/or
cysts (yes/no), their number (solitary (1) versus multiple
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nodules (2+)), and tumor size at its largest diameter in
millimeters. When multifocality was detected, the size of
the largest tumor was taken into account in the analysis.
Tumor size was analyzed as a continuous variable and then
subclassified into categories (first in 4 categories (≤10mm,
11-2mm, 21-40mm, and >40mm) and then in 2 categories
(≤10mm and>10mm)), and TC localization (on the nodule
or in the parenchyma), thyroid parenchyma invasion
(yes/no), effraction of the thyroid capsule (yes/no), and the
presence of vascular emboli (yes/no) were observed. Age at
TC diagnosis and tumor size were presented as means with
the standard deviation (SD) and medians with extreme
values, respectively. Data were presented for the entire study
period and for the 4 calendar time periods. Categorical and
continuous data were tested on univariate analysis using
two-tailed Fisher’s exact test, independent t-tests between
groups of two, and one-way analysis of variance (ANOVA)
among groups of three or more. Dichotomous outcomes
were analyzed using the chi-square test. After checking for
the normality assumption, the mean and SD were used to
express normally distributed data (such as age of the
patients) with a median and interquartile range used for
nonnormally distributed data (such as tumor size). A p value
< 0.05 was considered to indicate statistical significance.
Annual populations for years 1993 to 2013 for the district
of Oran (5-year age groups) were obtained from the National
Office of Statistics, Algeria (http://www.ons.dz/IMG/pdf/
CH1-DEMOGRAPHIE.pdf). Age-standardized incidence
rates (ASRs) of TC were computed by the direct standardiza-
tion method using the world standard population as a
reference [42] and were expressed per 100000 person-years.
ASRs were calculated for the entire cohort and by histology
to assess temporal trends. The data were managed using
Microsoft Excel 2010 and analyzed using SPSS for Windows
version 20.0 (SPSS Inc., Chicago, IL). ASRs were computed
using SEER∗Stat version 6.4.4 [45].
3. Results
Between 1993 and 2013, 17324 thyroid surgeries were
performed in Oran across the 43 healthcare institutions,
among which 7521 were permanent residents of Oran. Major
data sources were surgery services (n = 17), pathology labora-
tories (n = 11), medical oncology clinics (n = 2), radiotherapy
clinics (n = 2), endocrinology clinic (n = 1), and the nuclear
medicine facility (n = 1).
After validation of place of residence, histologic diagno-
sis, and elimination of duplicates, 1443 TC cases were
diagnosed over the study period (19.2% of all thyroid surger-
ies). TC data sources were represented by the nuclear medi-
cine facility (52.5%), pathology laboratories (27.0%), and
surgery services (16.6%). An increased number of thyroid
surgeries were observed over the study period, concomitant
with an increase in the number of thyroid cancer cases
detected (Figure 1). The ratio of thyroid surgeries to TC nar-
rowed significantly with time, which reflects a more rapid
increase in the frequency of TC compared with the number
of thyroid surgeries (1 TC out of 3.73 thyroid surgeries in
2008-2013 versus 1 TC out of 6.33 thyroid surgeries in
1993-1997, p < 0:001). Thyroid cancer age-standardized inci-
dence rates also showed a trend towards increased incidence
of overall TC and of PTC, while FTC decreased and other
histologic types remained relatively stable (Figure 2). Among
all TC patients, 1248 (86.5%) were women and 195 (13.5%)
men (female-to-male (F :M) sex ratio = 6:4 : 1), with no sig-
nificant variations over time (p = 0:76). Mean age at TC diag-
nosis (±SD) was 43:7 ± 14:8 years for women and 48:1 ± 15:3
years for men (p < 0:001).
A self-neck check was the most common circumstance of
diagnosis (83.1% for women and 69.8% for men) with a
significant increase in frequency over the study period
although for men, it was not statistically significant (71.9%
in 1993-1997 to 86.8% in 2008-2013 (p = 0:01) for women
and 33.3% in 1993-1997 to 78.3% in 2008-2013 for men
(p = 0:11)) (Table 1). A history of goiter or nodules was
found in 10% of women and 18.9% of men, decreasing
nonsignificantly over time (15.8% in 1993-1997 to 7.5% in
2008-2013 for women (p = 0:07) and 33.3% in 1993-1997 to
18.1% in 2008-2013 for men (p = 0:09)) (Table 1). An
incidental diagnosis, following medical imaging of the neck,
represented 1.2% of cases in women and 10.1% in men, with
a significant decrease over time for men (33.3% in 1993-1997
to 3.6% in 2008-2013, p < 0:01), while for women, there was
no clear trend (Table 1).
In 84.5% of women and 87.8% of men, there was no
reported history of thyroid diseases, with significant decreases
over time (Table 1). The proportion of TC patients who
reported a history of goiter significantly increased over time
(13.3% in 1993-1997 to 23.3% in 2008-2013 (p < 0:001) for
women and 2.9% in 1993-1997 to 25.0% in 2008-2013
(p < 0:01) for men). Based on 24 cases only, a significant trend
towards an increased number of patients with thyroiditis was
observed among females (3.3% in 1993-1997 to 5.0% in
2008-2013, p < 0:01) (Table 1).
For women and men, microscopic examination of the
thyroid specimen led to the diagnosis of thyroid cold nod-
ules (TCN) (49.7% and 47.1%, respectively), goiter (43.2%
and 47.7%, respectively), and thyroiditis (6.5% and 5.1%,
respectively), with no significant variations over time
(Table 1).
3.1. Anatomopathological Characteristics. Thyroid nodules
(TNs) were present in 93.5% of women and 90.3% of men
(Table 2). The frequency of TCs associated with TN
increased over time, although for men, the difference was
not statistically significant (81.1% in 1993-1997 to 95.1% in
2008-2013 (p < 0:001) for women and 80.8% in 1993-1997
to 87.7% in 2008-2013 (p = 0:2) for men). This increase was
driven by an increase in the frequency of thyroid multiple
nodules, significant only for women (21.7% in 1993-1997 to
40.7% in 2008-2013 (p < 0:01) and 20.0% in 1993-1997 to
34.0% in 2008-2013 (p = 0:81)) (Table 2).
The mean size of the TCs was 26:4 ± 17:3mm in women
and 29:7 ± 19:1mm in men (p = 0:14). For women and men,
microcarcinomas represented 21.3% and 16.5%, respectively,
and small carcinomas (≤20mm) represented 51% and 46.9%
of TCs, respectively, while carcinomas > 40mm represented
14.0% and 21.5%, respectively. Significant differences in TC
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distributions according to TC size and period of diagnosis were
observed. TCs > 20mm were predominant in 1993-2002, and
TCs ≤ 20mm in 2008-2013 for women (p < 0:001). For men,
similar distributions were observed for TC ≤ 20mm, while a
higher frequency of TC > 20mm was observed in 1998-2013
(p = 0:03). Over the study period, TC mean size significantly
decreased for women (32:6 ± 19:4mm in 1993-1997 to 24:4
± 16:8mm in 2008-2013) (p < 0:01), while for men, TC size
significantly increased (p = 0:048) (Table 2). The frequency of
microcarcinomas significantly increased for women (6.1% in
1993-1997 to 25.2% in 2008-2013, p < 0:001), while a nonsig-
nificant decrease in the frequency of TC > 40mmwas observed
(21.2% in 1993-1997 to 11.6% in 2008-2013, p = 0:15)
(Table 2).
Cancerous nodules accounted for 58.5% of TCs in women
and 46.6% in men, sparing the thyroid parenchyma in 82.6%
of women and 77.6% of men (Table 2). For women, the fre-
quency of TCs sparing the thyroid parenchyma significantly
increased over time (41.7% in 1993-1997 to 87.9% in 2008-
2013, p < 0:001), while for men, a significant decrease was
observed during the same time period (50% in 1998-2002 to
8% in 2008-2013, p = 0:025) (Table 2). Capsular effractions
were present in 57.7% of women and 54.2% of men, and
angioinvasions in 50.1% of women and 46.6% of men with a
significant decrease in frequency over time (Table 2).
For women and men, TC histologic types were repre-
sented by PTC (59.5% and 51.8%), FTC (30.4% and 25.6%),
carcinoma NOS (5.1% and 9.7%), ATC (1.6% and 5.1%),
and MCT (0.8% and 1.0%) (Table 2). Over the study period,
the frequency of PTCs significantly increased (from 42.7% to
69.8% in women (p < 0:001) and 23.1% to 67.0% in men
(p < 0:001)), while a significant decrease was observed for
FTC, carcinoma NOS, ATC, and all other specified carcino-
mas. PTCFV accounted for 16.3% and 6.3% of all histologic
types in women and men, respectively, with no significant
variations across the study period (Table 2).










1993-1997 1549 107 6.33:1 < 0.001
1998-2002 3370 300 4.43:1
2003-2007 5209 344 5.11:1
2008-2013 7196 692 3.73:1
⁎Number of patients residing in Oran who underwent thyroid surgery in a given time period/number of




































Figure 1: Trends of thyroid surgeries performed among residents of Oran, 1993-2013.
Abbreviations : PTC, papillary thyroid carcinoma ; FTC, follicular thyroid carcinoma ; 
ATC, anaplastic thyroid carcinoma ; MCT, medullary thyroid carcinoma ;

























































Figure 2: Age-standardized (world population) thyroid cancer
incidence, overall and for the major histologic types.
Abbreviations: PTC: papillary thyroid carcinoma; FTC: follicular
thyroid carcinoma; ATC: anaplastic thyroid carcinoma; MCT:
medullary thyroid carcinoma; NOS: not otherwise specified.
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4. Discussion
To our knowledge, this is the first study to use population-
based data to describe demographic, clinical, and pathologi-
cal patterns and trends of TC in an African country. From
1993 to 2013, 1443 new TC cases were diagnosed among
permanent residents in the district of Oran, Algeria, of which
1248 (86.5%) were women (sex ratio: 6.4 : 1). The self-neck
check was the most frequent circumstance of diagnosis and
increased over time. No prior history of thyroid disease was
reported in more than 85% of patients. TNs were observed
in more than 90% of TC patients, and their frequency
increased over the study period. The most frequent TC
histologic types were PTC, FTC, and carcinoma NOS. Over
the study period, the frequency of PTC increased while that
of FTC, ATC, and carcinoma NOS decreased. Tumor size
significantly decreased, with an increased frequency of
microcarcinomas.
Consistent with data from African cancer registries, TC
occurred in our cohort during the fourth decade of life [5].
However, in recent years, some studies have reported an
increased incidence of TC among younger individuals in
developed countries [8, 14]. TC rates were higher in women
compared with men in Oran (F :M ratio 6.4 : 1). A F :M ratio
of 5.9 : 1 was also reported in a previous study carried out in
two different districts in eastern Algeria (Guidoum et al.).
Worldwide, the F :M ratio for TC incidence varies from 2
to 12 [3], and this disparity by sex has been attributed to hor-
monal factors and greater use of healthcare services by
women compared with men [11, 33–35].
The trend towards increased incidence of TC observed in
our study has also been reported in two different regions cov-
ered by population-based cancer registries with cancer data
collected over two decades [40, 46]. Socioeconomic differ-
ences relating to access to healthcare services have been
hypothesized to influence TC incidence and trends [17].
However, this should not influence TC rates or trends in
Oran as free access to healthcare and universal insurance
coverage (public funded with no dependency on income
level) were implemented in Algeria in 1974. Thus, the general
population can be considered equal regarding the amount
and quality of healthcare available, suggesting that a detec-
tion effect would not fully explain the observed increase in
TC cases. Furthermore, since the early 1990s, the private sec-
tor has expanded dramatically and private clinics have mush-
roomed. Our finding that 96% of TC patients in the cohort
have undergone thyroid surgery in public hospitals contrasts
with the higher frequency of microscopic examination of
thyroid specimens performed in private pathology laborato-
ries (92%), which may reflect easy access to healthcare
services in both the public and private services. Oran is the
second largest and one of the most developed cities in Alge-
ria, a context that may have favored the increasing number
of individuals seeking healthcare across the study period
and undergoing thyroid surgery. Higher levels of education,
greater awareness of the disease in the general population,
and the increased frequency of thyroid surgery over the study
period may also explain part of the observed changes over
time. Three major changes in medical practice have occurred
in Oran over the study period and may explain part of the
observed trends: (1) large thyroidectomies were performed
more frequently over the past two decades and may have
led to the incidental discovery of small TC, (2) thyroid ultra-
sound was introduced in 1990, (3) and fine-needle aspiration
was introduced in 1998. Furthermore, all medical procedures
were standardized across the clinics making TC patients
equal regarding TC diagnosis and management.
The overall increase in TC in Oran was mainly due to a
rise in the frequency of PTC, while the frequency of other
histologic types decreased. A diagnostic effect alone would
have resulted in similar increases for all histologic types.
Other factors that vary with time may have contributed to
the observed trends, for example, iodine intake [30], obesity
[36–38], exposure to endocrine disruptors [39], use of fertil-
ity drugs [47], hormonal and reproductive factors [33–35],
and insulin resistance syndrome [48, 49]. In Algeria, apart
from iodine intake, obesity, and diabetes, little is known
about the prevalence of the other potential risk factors.
Iodine deficiency and supplementation may increase the
risk of benign thyroid diseases, which may lead to increased
rates of thyroid surgery and incidental discovery of subclini-
cal TC [50]. In addition, differences in risk according to the
histologic type have also been associated with iodine intake
[20, 21]. When iodine supplementation is introduced in a
population with a previous background of iodine deficiency,
there is a shift towards an increase in the PTC-to-FTC ratio
within 15 to 40 years, with no actual change in the overall
TC incidence [30]. Algeria was iodine-deficient with a high
prevalence of endemic goiter [50]. In 1967, the program of
table salt iodization was implemented, first in areas with high
prevalence of endemic goiter and nationwide since 1990 [51].
In our cohort, distributions of PTC and FTC were similar in
1993-1997. However, over the study period, the frequency of
PTC increased while that of FTC decreased, which may
reflect a shift from iodine-deficient to iodine sufficient-to-
excessive supplementation status. In a previous publication
by Guidoum et al., PTC was the predominant histologic type
in two districts in Northeastern Algeria [52].
In our study, a decrease in frequency of tumor aggressive-
ness features (capsular effractions and angioinvasions) over
time is consistent with a shift from FTC to the less aggressive
PTC and also early diagnosis in the context of iodine
supplementation.
The prevalence of TC in TN varies from 4% to 6.5% [30]
and is less frequent in multinodular goiters than in solitary
nodules among residents of regions with iodine deficiency
[30]. In our study, the prevalence of TC was substantially
higher at 19.2%. Among TC patients, 90.9% exhibited either
goiter or TCN. Goiters and nodules are considered
precancerous lesions that share risk factors with TC such as
iodine deficiency and exposure to ionizing radiation [2].
The significant increase in the prevalence of TN and chronic
thyroiditis across the study period may be associated with an
excessive nutritional iodine intake as reported in studies
conducted in other countries [30]. The increased number of
thyroid surgeries over the study period, with a systematic
use of total and near-total thyroidectomy in the context of
high prevalence of goiter and benign TNs, may have helped
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detect microcarcinomas in the studied population. In our
study, mean size of TC decreased among females but increased
in males. A few studies found a significant increase in small TC
over time in both women and men, but TC of larger sizes also
increased among men [7, 11, 23]. In France between 1983 and
2000, incidence of PTC 10-40mm increased from 0.38 per
100000 to 0.83 per 100000 in men and from 0.05 per 100000
to 0.17 per 100000 for PTCs > 40mm [11]. In Italy, significant
increases in small TCs were observed in 2001-2006; however,
TCs > 20mm also increased (APC: +18.4%) [23]. In the U.S.
for the period 1980-2005, 20% of the TC increase was due to
tumors > 20mm, and in 1988-2009, TC incidence of TC > 20
mm significantly increased [7]. While in developed countries,
increased TC incidence over the past several years has been
attributed to the use of medical imaging of the neck resulting
in an epidemic of incidentalomas [20–23], incidental detection
of TC in the course of medical imaging in our study occurred in
1.2% of women and 10.1% of men and decreased over time,
while the frequency of incidental discovery during microscopic
examination of the thyroid specimen by pathologists increased.
Obesity increases the risk of TC [36–38]. Insulin resis-
tance and subsequent hyperinsulinemia are present in 50%
of patients with PTC [48, 49], and a high BMI has increased
the risk of TC in women [36–38]. The rapid increase in the
prevalence of obesity and diabetes has paralleled the increase
in incidence of TC, in particular PTC in women [38]. In our
cohort, among the 298 TC patients with anthropometric
data, 64 (21.3%) had a BMI > 33 kg/m2 and 12 (4%) were
overweight. Changes in eating habits and lifestyle have
resulted in an increased prevalence of obesity in Algeria. In
2010, the prevalence of obesity among adults aged 35 to 70
years was 30.1% (95% CI: 27.8%-32.4%) in women and
9.1% (95% CI: 7.1%-11.0%) in men [53]. The prevalence of
diabetes among adults in Oran has increased between 1998
and 2009, from 7.1% to 10.5% in Oran [54].
Strengths of this study include the large number of TC
cases evaluated in an unselected and homogeneous popula-
tion. Oran is the second largest and most populated city in
Algeria (about 1.5 million inhabitants in 2014—about 5%
of the Algerian population). We have used the ENCR defini-
tions and the multisource approach to reach a high degree of
completeness of case ascertainment across the studied
period. Only TC cases with microscopic confirmation and
validated place of residence were included in the study. Data
collection processes also included a systematic recovery of
demographic, clinical, and anatomopathological features
and tumor size. In 1988, the WHO new classification of
morphologies considered the PTCFV to be PTC. Since our
study included patients diagnosed from 1993 onwards, we
do not expect that this revision has influenced the observed
trends for PTC. Also, the proportions of PTCFV were similar
in the 4 time periods assessed. The accuracy and complete-
ness of information on histology were also high resulting in
lower frequencies of cases with poorly specified TC histology
in later years, which reflects improved classification of poorly
specified histology by pathologists over time. Despite our
efforts to ensure data quality and completeness, a few data
limitations should be acknowledged. We failed to capture
TC patients treated in medical centers outside of the district
of Oran, but these patients represented less than 5% of the
cohort. In our cohort, we failed to find medical records and
pathology reports of all TC patients diagnosed during the
early period of the study, and information on clinical charac-
teristics, tumor size, nodules, and other microscopic charac-
teristics was not complete. The significant decrease in
missing data over time may reflect better data capture and
could explain part of the increasing trends concerning clini-
cal characteristics and some pathological features. However,
it is unlikely that these limitations have invalidated our study,
because the observed trends are consistent with the general
context that includes a history of iodine deficiency and
endemic goiter and the high frequency of nodules and goiter
in previously asymptomatic patients, and our findings con-
cerning trends of histologic types, tumor size, and demo-
graphics align well with previously published data.
In summary, our study revealed a sharp increase in TC
incidence that has tripled over the study period, and this trend
has paralleled an increased frequency of thyroid surgery, par-
ticularly in women. The increased number of patients seeking
healthcare spontaneously is compatible with the hypothesis of
the change in consumer behaviour and greater awareness of
thyroid pathology in the general public, probably due to
improvements in education. Striking observations include a
rise in TC cases limited to PTC, with decreasing proportions
of other histologic types, in particular FTC. The increasing
PTC-to-FTC ratio over the study period suggests that differ-
ences in iodine nutrition status over time might have affected
the observed trends. In conclusion, it is not possible to identify
the exact cause of the increasing TC trends in Algeria.
Increased diagnostic activity may have also played a role.
Future large-scale research will need to include information
on TC patients’ anthropometric characteristics, tumor size,
and TC stage to determine the role of iodine prophylaxis
among other factors in PTC and FTC patterns and trends.
Data Availability
The work described in the submitted article is the first part of
my PhD dissertation that I have not defended yet. Thus, I can-
not share my data immediately with the general public or the
scientific community. I am open to share all the data related to
this work after my PhD dissertation has taken place.
Additional Points
What Is New?. This is a cohort study of 1443 Algerian
patients diagnosed with thyroid cancer over a 21-year period.
Most patients sought a diagnosis following a self-neck check.
Thyroid nodules were associated with thyroid cancer in 90%
of patients. The incidence of the papillary carcinoma histotype
significantly increased over time, while that of the follicular
histotype significantly decreased. Tumor size significantly
decreased over time, but the frequency of larger tumors
increased. The frequency of thyroid cancers with capsular
effractions and angioinvasions decreased over time. The
increasing papillary-to-follicular carcinoma ratio may be due
9Journal of Cancer Epidemiology
to changes in iodine nutrition status in Algeria, although
changes in medical practice cannot be ruled out.
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